Brief: Promore Pharma Q2 Operating Loss Narrows To SEK 7.4 Million
Aug 28 (Reuters) - Promore Pharma AB PROMO.ST :
* (PUBL) INTERIM REPORT JANUARY - JUNE 2019
* Q2 NET SALES SEK 0.7 MILLION VERSUS SEK 0 MILLION YEAR AGO
* Q2 OPERATING LOSS SEK 7.4 MILLION VERSUS LOSS SEK 10.8
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr86v9s7
Further company coverage: PROMO.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on PMD Device Solutions AB
See all newsBrief: PMD Device Solutions Files For Bankruptcy
Brief: PMD Device Solutions Q3 EBITDA Loss Widens To SEK 8.9 Mln
Brief: Pmd Device Solutions Completes Sale Of Coala Life Monitor
Brief: PMDS’ Largest Shareholder Requests EGM To Appoint New Non-Executive Directors
Brief: PMDS Says RespiraSense Technology Demonstrates Capability In Predicting 7-Day Mortality